About Eqvita
Who we are
EqVita AG, founded in May 2024 as a University of Basel spin-off, aims to optimize individual care of children and adults with endocrine diseases.
Committed to innovation, implementation, and partnerships, EqVita focuses on translating research into individualized treatment to balance and enhance life.
Our Vision
Advancing optimized individual monitoring and treatment for endocrine diseases.
We use advanced AI and PMX data analytics developing digital health solutions. Our aim is to enable early detection and optimized individual care of children and adults with endocrine diseases.
Experienced leadership team
Dr. Gilbert Koch
CEO
Dr. Ralph Zahn
CFO
Prof. Michel Polak, MD PhD
CMO
Prof. Marc Pfister, MD
CSO
Dr. Delphine Geraud, MD PhD
Head Clinical Affairs & Business Development
Prof. Gabor Szinnai, MD PhD
Clinical Advisor